Hedge Fund - VenBio Select Advisor
United Therapeutics Corp (UTHR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $824,622,250 | 12.87% | 2,675,000 | $342.70 |
| 2 | 2024 - Q4 (2024-12-31) | $973,944,252 | 13.77% | 2,760,300 | $367.56 |
| 3 | 2024 - Q3 (2024-09-30) | $1,024,482,515 | 14.93% | 2,858,888 | $337.80 |
| 4 | 2024 - Q2 (2024-06-30) | $910,698,772 | 12.12% | 2,858,888 | $264.67 |
| 5 | 2024 - Q1 (2024-03-31) | $656,743,751 | 7.66% | 2,858,888 | $225.66 |
| 6 | 2023 - Q4 (2023-12-31) | $628,640,882 | 8.68% | 2,858,888 | $230.49 |
| 7 | 2023 - Q3 (2023-09-30) | $644,294,175 | 10.04% | 2,852,500 | $230.33 |
| 8 | 2023 - Q2 (2023-06-30) | $642,382,279 | 8.71% | 2,909,999 | $221.53 |
| 9 | 2023 - Q1 (2023-03-31) | $642,765,200 | 9.52% | 2,870,000 | $246.53 |
| 10 | 2022 - Q4 (2022-12-31) | $796,727,850 | 11.9% | 2,865,000 | $252.44 |
| 11 | 2022 - Q3 (2022-09-30) | $612,751,000 | 11.32% | 2,926,500 | $223.56 |
| 12 | 2022 - Q2 (2022-06-30) | $699,851,000 | 13.82% | 2,970,000 | $203.30 |
| 13 | 2022 - Q1 (2022-03-31) | $543,612,000 | 9.92% | 3,030,000 | $190.51 |
| 14 | 2021 - Q4 (2021-12-31) | $655,803,000 | 11.16% | 3,035,000 | $196.31 |
| 15 | 2021 - Q3 (2021-09-30) | $553,740,000 | 8.69% | 3,000,000 | $196.97 |
| 16 | 2021 - Q2 (2021-06-30) | $538,230,000 | 9.36% | 3,000,000 | $190.45 |
| 17 | 2021 - Q1 (2021-03-31) | $501,810,000 | 8.66% | 3,000,000 | $166.73 |
| 18 | 2020 - Q4 (2020-12-31) | $432,602,000 | 7.45% | 2,850,000 | $131.23 |
The displayed share prices are average quarterly stock market prices.